Characterizing pluripotent stem cells using the TaqMan® hPSC scorecard™ panel

Methods in Molecular Biology

Volumn 1307, Issue , 2015, Pages 25-37

  Fergus, Jeffrey ^a   Quintanilla, Rene ^a   Lakshmipathy, Uma ^a  

^a NONE

Author keywords

Gene expression assay; Molecular characterization; Pluripotent stem cells; Self renewal; Taqman hPSC Scorecard assay; Trilineage differentiation potential

Indexed keywords

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; EMBRYO; EPIGENETICS; GENE EXPRESSION; GENETIC ANALYSIS; GERM LAYER; HOUSEKEEPING GENE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STANDARDIZATION; ANIMAL; CELL CULTURE; COMPUTER PROGRAM; CYTOLOGY; EMBRYOID BODY; FEEDER CELL; HUMAN; PROCEDURES;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYOID BODIES; FEEDER CELLS; HUMANS; MICE; PLURIPOTENT STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; SOFTWARE;

EID: 84938828384     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/7651_2014_109     Document Type: Article

References (17)

1. Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3:595-605.
2. Malik N, Rao MS (2013) A review of the methods for human iPSC derivation. Methods Mol Biol 997:23-33.
3. Ko HC, Gelb BD (2014) Concise review: drug discovery in the age ofthe induced pluripotent stem cell. Stem Cells Transl Med 3:500-509.
4. Rao M, Gottesfeld JM (2014) Introduction to thematic minireview series: development of human therapeutics based on induced pluripo-tent stem cell (iPSC) technology. J Biol Chem 289:4553-4554.
5. Marti M, Mulero L, Pardo C et al (2013) Characterization ofpluripotent stem cells. Nat Protoc 8:223-253.
6. Wesselschmidt RL (2011) The teratoma assay: an in vivo assessment ofpluripotency. Methods Mol Biol 767:231-241.
7. Gertow K, Przyborski S, Loring JF et al (2007) Isolation of human embryonic stem cell-derived teratomas for the assessment of pluri-potency. Curr Protoc Stem Cell Biol. Chapter 1:Unit1B 4.
8. Muller FJ, Goldmann J, Loser P et al (2010) A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 6:412-414.
9. Daley GQ, Lensch MW, Jaenisch R et al (2009) Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 4:200-201, author reply 202.
10. Muller FJ, Schuldt BM, Williams R et al (2011) A bioinformatic assay for pluripotency in human cells. Nat Methods 8:315-317.
11. Guenther MG, Frampton GM, Soldner F et al (2010) Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7:249-257.
12. Chin MH, Mason MJ, Xie W et al (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111-123.
13. Narsinh KH, Plews J, Wu JC (2011) Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol Ther 19:635-638.
14. Hu BY, Weick JP, Yu J et al (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107:4335-4340.
15. Narsinh KH, Sun N, Sanchez-Freire V et al (2011) Single cell transcriptional profiling reveals heterogeneity ofhuman induced plurip-otent stem cells. J Clin Invest 121:1217-1221.
16. Feng Q, Lu SJ, Klimanskaya I et al (2010) Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704-712.
17. Bock C, Kiskinis E, Verstappen G et al (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization ofpluripotent cell lines. Cell 144:439-452.